# Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

> **NCT02330679** · PHASE4 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 61 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Desvenlafaxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02330679
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2015-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330679, "Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02330679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*